A recently published report, sponsored by Novartis, has described the potential benefits of the NHS only paying for drugs that actually work as a new model to address affordability and reduce risks within the health system.
According to research recently performed by SEA Vision and Zenith Technologies, 40% of pharmaceutical industry professionals are lacking confidence in their ability to meet the upcoming US and European serialisation deadlines.
GlaxoSmithKline (GSK) has made several announcements regarding its forthcoming plans to improve the efficiency and competitiveness of its manufacturing network.
The fourth CPhI Korea is set to take place in August in Seoul, where the event organisers have revealed that there will be a 13% rise in the number of exhibitors and double the amount of overseas buyers since 2015.
In this instalment to our human interest series, we speak to the new business development executive to the North American clinical sales team of PCI Clinical Services, Jamie Weishaar.
Partner to the healthcare and pharma industry, Gerresheimer has announced it will complete its product portfolio of prefillable syringes through an exclusive licence from West Pharmaceutical Services.
Lonza has announced that, following receipt of all required regulatory approvals, it has completed its acquisition of Capsugel for $5.5 billion in cash, including refinancing of existing Capsugel debt of $2 billion.
Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets.
In our inaugural Q&A of our new ‘Meet the maker’ series, EPM gets to know Ashley Parish, who has recently been appointed vice president, strategic alliances of teckro — a global life sciences mobile technology company
With patient adherence and prevention of overdose hot topics for pharma, regulatory and healthcare sectors, the rise of implants for the sustained and controlled delivery of drugs is perhaps an inevitable trend.
The Sartorius and Science Prize for Regenerative Medicine & Cell Therapy is focused towards scientists advancing research within the relevant fields, with the winner receiving $25,000 in prize money and being published in Science magazine
